Immunovant, Inc. (IMVT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1249718,
"name": "Immunovant, Inc.",
"stock_name": "Immunovant, Inc.",
"full_name": "Immunovant, Inc.",
"name_url": "stocks-analysis/immunovant-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "22.91",
"chg": 0.89,
"chgp": "4.04%",
"dir": 1,
"prev_price": "22.02",
"mcapval": "2,853.57",
"mcap": "",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2320,
"indexname": "S&P 500",
"isin": "US45258J1025",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "2.64 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/immunovant-inc-1249718-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3673736",
"imagepath": "",
"date": "2025-11-05 11:23:53",
"description": "As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a mildly bullish stance for both weekly and monthly periods. Daily moving averages are bullish, suggesting positive momentum. However, the KST shows a mixed signal with a bullish weekly and bearish monthly reading. The Dow Theory indicates no trend in both weekly and monthly time frames.\n\nIn terms of performance, Immunovant has outperformed the S&P 500 over the past week and month, with returns of 12.88% and 43.14%, respectively, compared to the S&P 500's 0.71% and 1.92%. However, it has underperformed over the year and five years. Overall, the current technical stance is mildly bullish, supported by several indicators, despite mixed signals in some areas...."
},
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3670913",
"imagepath": "",
"date": "2025-11-04 11:35:43",
"description": "As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and KST. However, the monthly MACD and KST are bearish, indicating mixed signals across time frames. The daily moving averages are mildly bearish, which tempers the overall bullish stance. The Dow Theory shows a mildly bullish position on both weekly and monthly charts, while the On-Balance Volume is also mildly bullish. \n\nIn terms of returns, the stock has outperformed the S&P 500 over the past week and month, with returns of 10.97% and 40.71% respectively, but has underperformed over the year and five years. Overall, the current stance is mildly bullish, driven primarily by the weekly indicators...."
},
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3666521",
"imagepath": "",
"date": "2025-11-03 11:35:29",
"description": "As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the mildly bullish stance. Moving averages show a mildly bearish signal on the daily chart, which contrasts with the overall trend. Dow Theory and OBV both indicate a mildly bullish position on the weekly and monthly time frames.\n\nIn terms of performance, Immunovant has outperformed the S&P 500 over the past week and month, with returns of 30.31% and 51.04%, respectively, compared to 0.71% and 1.92% for the index. However, the year-to-date and one-year returns are negative at -0.36% and -15.65%, significantly lagging behind the S&P 500's gains of 16.30% and 19.89%. Overall, the current technical stance is mildly bulli..."
},
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3664636",
"imagepath": "",
"date": "2025-11-02 11:19:31",
"description": "As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, supported by bullish signals from Bollinger Bands and KST, while the monthly indicators show a bearish MACD and KST. The moving averages indicate a mildly bearish stance on the daily timeframe. Dow Theory reflects a mildly bullish trend in both weekly and monthly perspectives. The stock has outperformed the S&P 500 significantly over the past week and month, with returns of 30.31% and 51.04% respectively, but has underperformed over the longer term, particularly year-to-date and over the past year. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD, Bollinger Bands, and KST indicators...."
},
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3582532",
"imagepath": "",
"date": "2025-09-30 11:18:54",
"description": "As of 26 September 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages and the KST indicators, both indicating bearish momentum. The weekly MACD shows a mildly bullish signal, but this is offset by the monthly bearish indicators in MACD and Bollinger Bands. The stock has underperformed against the S&P 500 year-to-date and over the past year, with returns of -34.48% and -42.67%, respectively, compared to the S&P 500's gains of 12.96% and 15.64%...."
},
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3578375",
"imagepath": "",
"date": "2025-09-29 11:19:41",
"description": "As of 26 September 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages and the KST, which are both bearish. The weekly MACD is mildly bullish, but the monthly MACD remains bearish, indicating mixed signals across time frames. The Bollinger Bands show a bullish signal on the weekly but a mildly bearish signal on the monthly, further contributing to the overall mildly bearish outlook. \n\nIn terms of performance, the stock has underperformed the S&P 500 year-to-date and over the past year, with returns of -34.48% and -42.67%, respectively, compared to the S&P 500's 12.96% and 15.64%. However, it has significantly outperformed the benchmark over the past three years with a return of 259.07% versus 81.77%...."
},
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3576806",
"imagepath": "",
"date": "2025-09-28 11:12:58",
"description": "As of 26 September 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators such as the weekly MACD showing a mildly bullish signal, while the monthly MACD remains bearish. The daily moving averages are also mildly bearish, and both the KST and OBV indicate bearish trends on a weekly and monthly basis. The Bollinger Bands suggest a bullish outlook on the weekly timeframe but are mildly bearish on the monthly. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 9.81% and 7.63% respectively, but it has significantly underperformed on a year-to-date and one-year basis, with declines of -34.48% and -42.67%. Overall, the technical indicators reflect a cautious outlook despite some short-term strength...."
},
{
"title": "Is Immunovant, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunovant-inc-technically-bullish-or-bearish-3548101",
"imagepath": "",
"date": "2025-09-20 20:09:43",
"description": "As of 27 August 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The weekly MACD is mildly bullish, but the monthly MACD remains bearish. The Bollinger Bands indicate a bearish trend on the weekly and a mildly bearish trend on the monthly. Daily moving averages are bearish, while the KST and OBV show mild bullishness on the weekly but bearishness on the monthly. \n\nIn terms of performance, Immunovant has underperformed the S&P 500 across multiple periods, with a year-to-date return of -37.83% compared to the S&P 500's 12.22%, and a one-year return of -46.71% versus the S&P 500's 17.14%...."
}
],
"total": 12,
"sid": "1249718",
"stock_news_url": "https://www.marketsmojo.com/news/immunovant-inc-1249718"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Is Immunovant, Inc. technically bullish or bearish?

2025-11-05 11:23:53

As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a mildly bullish stance for both weekly and monthly periods. Daily moving averages are bullish, suggesting positive momentum. However, the KST shows a mixed signal with a bullish weekly and bearish monthly reading. The Dow Theory indicates no trend in both weekly and monthly time frames. In terms of performance, Immunovant has outperformed the S&P 500 over the past week and month, with returns of 12.88% and 43.14%, respectively, compared to the S&P 500's 0.71% and 1.92%. However, it has underperformed over the year and five years. Overall, the current technical stance is mildly bullish, supported by several indicators, despite mixed signals in some areas....

Is Immunovant, Inc. technically bullish or bearish?

2025-11-04 11:35:43

As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and KST. However, the monthly MACD and KST are bearish, indicating mixed signals across time frames. The daily moving averages are mildly bearish, which tempers the overall bullish stance. The Dow Theory shows a mildly bullish position on both weekly and monthly charts, while the On-Balance Volume is also mildly bullish. In terms of returns, the stock has outperformed the S&P 500 over the past week and month, with returns of 10.97% and 40.71% respectively, but has underperformed over the year and five years. Overall, the current stance is mildly bullish, driven primarily by the weekly indicators....

Is Immunovant, Inc. technically bullish or bearish?

2025-11-03 11:35:29

As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on both weekly and monthly charts, supporting the mildly bullish stance. Moving averages show a mildly bearish signal on the daily chart, which contrasts with the overall trend. Dow Theory and OBV both indicate a mildly bullish position on the weekly and monthly time frames. In terms of performance, Immunovant has outperformed the S&P 500 over the past week and month, with returns of 30.31% and 51.04%, respectively, compared to 0.71% and 1.92% for the index. However, the year-to-date and one-year returns are negative at -0.36% and -15.65%, significantly lagging behind the S&P 500's gains of 16.30% and 19.89%. Overall, the current technical stance is mildly bulli...

Is Immunovant, Inc. technically bullish or bearish?

2025-11-02 11:19:31

As of 31 October 2025, the technical trend for Immunovant, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, supported by bullish signals from Bollinger Bands and KST, while the monthly indicators show a bearish MACD and KST. The moving averages indicate a mildly bearish stance on the daily timeframe. Dow Theory reflects a mildly bullish trend in both weekly and monthly perspectives. The stock has outperformed the S&P 500 significantly over the past week and month, with returns of 30.31% and 51.04% respectively, but has underperformed over the longer term, particularly year-to-date and over the past year. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD, Bollinger Bands, and KST indicators....

Is Immunovant, Inc. technically bullish or bearish?

2025-09-30 11:18:54

As of 26 September 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages and the KST indicators, both indicating bearish momentum. The weekly MACD shows a mildly bullish signal, but this is offset by the monthly bearish indicators in MACD and Bollinger Bands. The stock has underperformed against the S&P 500 year-to-date and over the past year, with returns of -34.48% and -42.67%, respectively, compared to the S&P 500's gains of 12.96% and 15.64%....

Is Immunovant, Inc. technically bullish or bearish?

2025-09-29 11:19:41

As of 26 September 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages and the KST, which are both bearish. The weekly MACD is mildly bullish, but the monthly MACD remains bearish, indicating mixed signals across time frames. The Bollinger Bands show a bullish signal on the weekly but a mildly bearish signal on the monthly, further contributing to the overall mildly bearish outlook. In terms of performance, the stock has underperformed the S&P 500 year-to-date and over the past year, with returns of -34.48% and -42.67%, respectively, compared to the S&P 500's 12.96% and 15.64%. However, it has significantly outperformed the benchmark over the past three years with a return of 259.07% versus 81.77%....

Is Immunovant, Inc. technically bullish or bearish?

2025-09-28 11:12:58

As of 26 September 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators such as the weekly MACD showing a mildly bullish signal, while the monthly MACD remains bearish. The daily moving averages are also mildly bearish, and both the KST and OBV indicate bearish trends on a weekly and monthly basis. The Bollinger Bands suggest a bullish outlook on the weekly timeframe but are mildly bearish on the monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 9.81% and 7.63% respectively, but it has significantly underperformed on a year-to-date and one-year basis, with declines of -34.48% and -42.67%. Overall, the technical indicators reflect a cautious outlook despite some short-term strength....

Is Immunovant, Inc. technically bullish or bearish?

2025-09-20 20:09:43

As of 27 August 2025, the technical trend for Immunovant, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The weekly MACD is mildly bullish, but the monthly MACD remains bearish. The Bollinger Bands indicate a bearish trend on the weekly and a mildly bearish trend on the monthly. Daily moving averages are bearish, while the KST and OBV show mild bullishness on the weekly but bearishness on the monthly. In terms of performance, Immunovant has underperformed the S&P 500 across multiple periods, with a year-to-date return of -37.83% compared to the S&P 500's 12.22%, and a one-year return of -46.71% versus the S&P 500's 17.14%....

View All News